A hazai gyermekonkológia az ezredfordulón

Translated title of the contribution: Pediatric oncology in Hungary in the new millennium

Research output: Contribution to journalArticle

Abstract

Pediatric malignancies are the most frequent causes of death among 1-15 year old children. These children are treated in 10 pediatric oncology centres in Hungary with therapy based on the same protocols. The author emphasises the importance of late side effects of the therapy, especially the cardiotoxicity, decreased fertility, secondary tumors and the neuropsychologic sequelae. In pediatric oncology, regular check-ups of all affected children is the best way for secondary prevention. Molecular genetic studies and minimal residual disease prove to be valuable prognostic factors. New trends of therapy based on better knowledge of molecular biology and immunological characteristics of tumor cells are also mentioned.

Original languageHungarian
Pages (from-to)636-639
Number of pages4
JournalLege Artis Medicinae
Volume11
Issue number10
Publication statusPublished - 2001

Fingerprint

Hungary
Pediatrics
Molecular Biology
Neoplasms
Residual Neoplasm
Secondary Prevention
Fertility
Cause of Death
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A hazai gyermekonkológia az ezredfordulón. / Schuler, D.

In: Lege Artis Medicinae, Vol. 11, No. 10, 2001, p. 636-639.

Research output: Contribution to journalArticle

@article{28533517156945e69509256e2ebaac1c,
title = "A hazai gyermekonkol{\'o}gia az ezredfordul{\'o}n",
abstract = "Pediatric malignancies are the most frequent causes of death among 1-15 year old children. These children are treated in 10 pediatric oncology centres in Hungary with therapy based on the same protocols. The author emphasises the importance of late side effects of the therapy, especially the cardiotoxicity, decreased fertility, secondary tumors and the neuropsychologic sequelae. In pediatric oncology, regular check-ups of all affected children is the best way for secondary prevention. Molecular genetic studies and minimal residual disease prove to be valuable prognostic factors. New trends of therapy based on better knowledge of molecular biology and immunological characteristics of tumor cells are also mentioned.",
keywords = "Antineoplastic agents, Late side effects of therapy, Paediatric oncology",
author = "D. Schuler",
year = "2001",
language = "Hungarian",
volume = "11",
pages = "636--639",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "10",

}

TY - JOUR

T1 - A hazai gyermekonkológia az ezredfordulón

AU - Schuler, D.

PY - 2001

Y1 - 2001

N2 - Pediatric malignancies are the most frequent causes of death among 1-15 year old children. These children are treated in 10 pediatric oncology centres in Hungary with therapy based on the same protocols. The author emphasises the importance of late side effects of the therapy, especially the cardiotoxicity, decreased fertility, secondary tumors and the neuropsychologic sequelae. In pediatric oncology, regular check-ups of all affected children is the best way for secondary prevention. Molecular genetic studies and minimal residual disease prove to be valuable prognostic factors. New trends of therapy based on better knowledge of molecular biology and immunological characteristics of tumor cells are also mentioned.

AB - Pediatric malignancies are the most frequent causes of death among 1-15 year old children. These children are treated in 10 pediatric oncology centres in Hungary with therapy based on the same protocols. The author emphasises the importance of late side effects of the therapy, especially the cardiotoxicity, decreased fertility, secondary tumors and the neuropsychologic sequelae. In pediatric oncology, regular check-ups of all affected children is the best way for secondary prevention. Molecular genetic studies and minimal residual disease prove to be valuable prognostic factors. New trends of therapy based on better knowledge of molecular biology and immunological characteristics of tumor cells are also mentioned.

KW - Antineoplastic agents

KW - Late side effects of therapy

KW - Paediatric oncology

UR - http://www.scopus.com/inward/record.url?scp=0035687651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035687651&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 636

EP - 639

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 10

ER -